{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,15]],"date-time":"2026-09-15T20:15:45Z","timestamp":1789503345866,"version":"build-2803163510"},"reference-count":45,"publisher":"Elsevier BV","issue":"9","license":[{"start":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T00:00:00Z","timestamp":1693526400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T00:00:00Z","timestamp":1693526400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","dldjournalonline.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Digestive and Liver Disease"],"published-print":{"date-parts":[[2023,9]]},"DOI":"10.1016\/j.dld.2023.02.008","type":"journal-article","created":{"date-parts":[[2023,2,27]],"date-time":"2023-02-27T21:13:02Z","timestamp":1677532382000},"page":"1201-1207","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":21,"title":["Exploring the spectrum of incidental gastric polyps in autoimmune gastritis"],"prefix":"10.1016","volume":"55","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-3214-8192","authenticated-orcid":false,"given":"Sara","family":"Massironi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alessandra","family":"Elvevi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Camilla","family":"Gallo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alice","family":"Laffusa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna","family":"Tortorella","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pietro","family":"Invernizzi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.dld.2023.02.008_bib0001","doi-asserted-by":"crossref","first-page":"1524","DOI":"10.1038\/ajg.2009.139","article-title":"The current spectrum of gastric polyps: a 1-year national study of over 120,000 patients","volume":"104","author":"Carmack","year":"2009","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.dld.2023.02.008_bib0002","first-page":"164","article-title":"Prevalence of benign gastric polyps in a large pathology database","volume":"47","author":"Sonnenberg","year":"2015","journal-title":"Dig Liver Dis Off J Ital Soc Gastroenterol Ital Assoc Study Liver"},{"key":"10.1016\/j.dld.2023.02.008_bib0003","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1186\/s12876-022-02154-8","article-title":"Gastric polyps: a 10-year analysis of 18,496 upper endoscopies","volume":"22","author":"Yacoub","year":"2022","journal-title":"BMC Gastroenterol"},{"key":"10.1016\/j.dld.2023.02.008_bib0004","doi-asserted-by":"crossref","first-page":"791","DOI":"10.4251\/wjgo.v12.i8.791","article-title":"Gastrointestinal neuroendocrine tumors in 2020","volume":"12","author":"Ahmed","year":"2020","journal-title":"World J Gastrointest Oncol"},{"key":"10.1016\/j.dld.2023.02.008_bib0005","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1016\/j.bpg.2017.06.001","article-title":"Evaluation and management of gastric epithelial polyps","volume":"31","author":"Castro","year":"2017","journal-title":"Best Pract Res Clin Gastroenterol"},{"key":"10.1016\/j.dld.2023.02.008_bib0006","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1007\/s004280000330","article-title":"Gastric polyps: an update of their pathology and biological significance","volume":"437","author":"Oberhuber","year":"2000","journal-title":"Virchows Arch Int J Pathol"},{"key":"10.1016\/j.dld.2023.02.008_bib0007","doi-asserted-by":"crossref","first-page":"8883","DOI":"10.3748\/wjg.v22.i40.8883","article-title":"Pathophysiological and clinical aspects of gastric hyperplastic polyps","volume":"22","author":"Markowski","year":"2016","journal-title":"World J Gastroenterol"},{"key":"10.1016\/j.dld.2023.02.008_bib0008","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1097\/00000478-200104000-00010","article-title":"Hyperplastic polyps of the stomach: associations with histologic patterns of gastritis and gastric atrophy","volume":"25","author":"Abraham","year":"2001","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.dld.2023.02.008_bib0009","doi-asserted-by":"crossref","first-page":"1825","DOI":"10.2169\/internalmedicine.56.8040","article-title":"Gastric hyperplastic polyps associated with proton pump inhibitor use in a case without a history of helicobacter pylori infection","volume":"56","author":"Miyamoto","year":"2017","journal-title":"Intern Med Tokyo Jpn"},{"key":"10.1016\/j.dld.2023.02.008_bib0010","doi-asserted-by":"crossref","first-page":"1397","DOI":"10.3109\/00365521.2015.1054426","article-title":"Gastric neuroendocrine neoplasms and proton pump inhibitors: fact or coincidence?","volume":"50","author":"Cavalcoli","year":"2015","journal-title":"Scand J Gastroenterol"},{"key":"10.1016\/j.dld.2023.02.008_bib0011","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1186\/s12876-016-0537-x","article-title":"Malignant transformation of a gastric hyperplastic polyp in a context of Helicobacter pylori-negative autoimmune gastritis: a case report","volume":"16","author":"Yamanaka","year":"2016","journal-title":"BMC Gastroenterol"},{"key":"10.1016\/j.dld.2023.02.008_bib0012","doi-asserted-by":"crossref","first-page":"1141","DOI":"10.1136\/gut.24.12.1141","article-title":"Gastroscopic screening in 80 patients with pernicious anaemia","volume":"24","author":"Stockbr\u00fcgger","year":"1983","journal-title":"Gut"},{"key":"10.1016\/j.dld.2023.02.008_bib0013","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1016\/j.autrev.2018.08.011","article-title":"The changing face of chronic autoimmune atrophic gastritis: an updated comprehensive perspective","volume":"18","author":"Massironi","year":"2019","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.dld.2023.02.008_bib0014","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1038\/s41572-020-0187-8","article-title":"Autoimmune gastritis","volume":"6","author":"Lenti","year":"2020","journal-title":"Nat Rev Dis Primer"},{"key":"10.1016\/j.dld.2023.02.008_bib0015","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1111\/j.1523-5378.1997.tb00060.x","article-title":"Atrophic body gastritis: distinct features associated with Helicobacter pylori infection","volume":"2","author":"Annibale","year":"1997","journal-title":"Helicobacter"},{"key":"10.1016\/j.dld.2023.02.008_bib0016","doi-asserted-by":"crossref","first-page":"2071","DOI":"10.1038\/ajg.2009.231","article-title":"Reassessment of intrinsic factor and parietal cell autoantibodies in atrophic gastritis with respect to cobalamin deficiency","volume":"104","author":"Lahner","year":"2009","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.dld.2023.02.008_bib0017","doi-asserted-by":"crossref","first-page":"1325","DOI":"10.1053\/j.gastro.2021.06.078","article-title":"AGA clinical practice update on the diagnosis and management of atrophic gastritis: expert review","volume":"161","author":"Shah","year":"2021","journal-title":"Gastroenterology"},{"key":"10.1016\/j.dld.2023.02.008_bib0018","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1016\/j.gtc.2013.01.002","article-title":"Gastric cancer: overview","volume":"42","author":"Correa","year":"2013","journal-title":"Gastroenterol Clin North Am"},{"key":"10.1016\/j.dld.2023.02.008_bib0019","first-page":"1621","volume":"51","author":"Lahner","year":"2019","journal-title":"Dig Liver Dis Off J Ital Soc Gastroenterol Ital Assoc Study Liver"},{"key":"10.1016\/j.dld.2023.02.008_bib0020","doi-asserted-by":"crossref","first-page":"2177","DOI":"10.3748\/wjg.15.2177","article-title":"Gastric carcinoids: between underestimation and overtreatment","volume":"15","author":"Massironi","year":"2009","journal-title":"World J Gastroenterol"},{"key":"10.1016\/j.dld.2023.02.008_bib0021","first-page":"1456","article-title":"Tumour type and size are prognostic factors in gastric neuroendocrine neoplasia: a multicentre retrospective study","volume":"51","author":"Panzuto","year":"2019","journal-title":"Dig Liver Dis Off J Ital Soc Gastroenterol Ital Assoc Study Liver"},{"key":"10.1016\/j.dld.2023.02.008_bib0022","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1530\/eje.1.01862","article-title":"Plasma chromogranin A in patients with autoimmune chronic atrophic gastritis, enterochromaffin-like cell lesions and gastric carcinoids","volume":"152","author":"Peracchi","year":"2005","journal-title":"Eur J Endocrinol"},{"key":"10.1016\/j.dld.2023.02.008_bib0023","doi-asserted-by":"crossref","first-page":"646","DOI":"10.5009\/gnl20036","article-title":"Proton pump inhibitor-related gastric mucosal changes","volume":"15","author":"Kim","year":"2021","journal-title":"Gut Liver"},{"key":"10.1016\/j.dld.2023.02.008_bib0024","doi-asserted-by":"crossref","first-page":"1161","DOI":"10.1097\/00000478-199610000-00001","article-title":"Classification and grading of gastritis. The updated Sydney System. International Workshop on the Histopathology of Gastritis, Houston 1994","volume":"20","author":"Dixon","year":"1996","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.dld.2023.02.008_bib0025","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1159\/000443168","article-title":"Vienna Consensus Conference participants. ENETS consensus guidelines update for gastroduodenal neuroendocrine neoplasms","volume":"103","author":"Delle Fave","year":"2016","journal-title":"Neuroendocrinology"},{"key":"10.1016\/j.dld.2023.02.008_bib0026","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1136\/gut.2006.106666","article-title":"Gastritis staging in clinical practice: the OLGA staging system","volume":"56","author":"Rugge","year":"2007","journal-title":"Gut"},{"key":"10.1016\/j.dld.2023.02.008_bib0027","doi-asserted-by":"crossref","first-page":"1150","DOI":"10.1016\/j.gie.2009.12.029","article-title":"The staging of gastritis with the OLGA system by using intestinal metaplasia as an accurate alternative for atrophic gastritis","volume":"71","author":"Capelle","year":"2010","journal-title":"Gastrointest Endosc"},{"key":"10.1016\/j.dld.2023.02.008_bib0028","first-page":"579","article-title":"The significance of OLGA and OLGIM staging systems in the risk assessment of gastric cancer: a systematic review and meta-analysis","volume":"21","author":"Yue","year":"2018","journal-title":"Gastric Cancer Off J Int Gastric Cancer Assoc Jpn Gastric Cancer Assoc"},{"key":"10.1016\/j.dld.2023.02.008_bib0029","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/0950-3528(93)90035-Q","article-title":"Enterochromaffin-like (ECL) cells and their growths: relationships to gastrin, reduced acid secretion and gastritis","volume":"7","author":"Solcia","year":"1993","journal-title":"Baillieres Clin Gastroenterol"},{"key":"10.1016\/j.dld.2023.02.008_bib0030","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1111\/his.13975","article-title":"WHO Classification of Tumours Editorial Board. The 2019 WHO classification of tumours of the digestive system","volume":"76","author":"Nagtegaal","year":"2020","journal-title":"Histopathology"},{"key":"10.1016\/j.dld.2023.02.008_bib0031","first-page":"1725","article-title":"The ENETS TNM staging and grading system accurately predict prognosis in patients with rectal NENs","volume":"51","author":"Capurso","year":"2019","journal-title":"Dig Liver Dis Off J Ital Soc Gastroenterol Ital Assoc Study Liver"},{"key":"10.1016\/j.dld.2023.02.008_bib0032","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1080\/17474124.2020.1718491","article-title":"A current clinical overview of atrophic gastritis","volume":"14","author":"Annibale","year":"2020","journal-title":"Expert Rev Gastroenterol Hepatol"},{"key":"10.1016\/j.dld.2023.02.008_bib0033","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1002\/ijc.2910530114","article-title":"Fundal atrophic gastritis as a risk factor for gastric cancer","volume":"53","author":"Tatsuta","year":"1993","journal-title":"Int J Cancer"},{"key":"10.1016\/j.dld.2023.02.008_bib0034","doi-asserted-by":"crossref","first-page":"1105","DOI":"10.1136\/gut.31.10.1105","article-title":"Development of gastric dysplasia in pernicious anaemia: a clinical and endoscopic follow up study of 80 patients","volume":"31","author":"Armbrecht","year":"1990","journal-title":"Gut"},{"key":"10.1016\/j.dld.2023.02.008_bib0035","doi-asserted-by":"crossref","first-page":"1279","DOI":"10.3748\/wjg.v18.i12.1279","article-title":"Risk for gastric neoplasias in patients with chronic atrophic gastritis: a critical reappraisal","volume":"18","author":"Vannella","year":"2012","journal-title":"World J Gastroenterol"},{"key":"10.1016\/j.dld.2023.02.008_bib0036","first-page":"978","article-title":"Intermittent treatment of recurrent type-1 gastric carcinoids with somatostatin analogues in patients with chronic autoimmune atrophic gastritis","volume":"47","author":"Massironi","year":"2015","journal-title":"Dig Liver Dis Off J Ital Soc Gastroenterol Ital Assoc Study Liver"},{"key":"10.1016\/j.dld.2023.02.008_bib0037","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1007\/s10654-010-9482-0","article-title":"Incidence of chronic atrophic gastritis: systematic review and meta-analysis of follow-up studies","volume":"25","author":"Adamu","year":"2010","journal-title":"Eur J Epidemiol"},{"key":"10.1016\/j.dld.2023.02.008_bib0038","doi-asserted-by":"crossref","first-page":"1449","DOI":"10.1097\/00042737-200112000-00008","article-title":"Atrophic body gastritis patients with enterochromaffin-like cell dysplasia are at increased risk for the development of type I gastric carcinoid","volume":"13","author":"Annibale","year":"2001","journal-title":"Eur J Gastroenterol Hepatol"},{"key":"10.1016\/j.dld.2023.02.008_bib0039","doi-asserted-by":"crossref","first-page":"1361","DOI":"10.1111\/j.1365-2036.2011.04659.x","article-title":"Development of type I gastric carcinoid in patients with chronic atrophic gastritis","volume":"33","author":"Vannella","year":"2011","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.dld.2023.02.008_bib0040","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1007\/s11912-021-01029-7","article-title":"Epidemiology, incidence, and prevalence of neuroendocrine neoplasms: are there global differences?","volume":"23","author":"Das","year":"2021","journal-title":"Curr Oncol Rep"},{"key":"10.1016\/j.dld.2023.02.008_bib0041","doi-asserted-by":"crossref","first-page":"1042","DOI":"10.1111\/j.1365-2036.2010.04268.x","article-title":"Risk factors for progression to gastric neoplastic lesions in patients with atrophic gastritis","volume":"31","author":"Vannella","year":"2010","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.dld.2023.02.008_bib0042","article-title":"Autoimmune gastritis: long-term natural history in na\u00efve Helicobacter pylori-negative patients","author":"Rugge","year":"2022","journal-title":"Gut"},{"key":"10.1016\/j.dld.2023.02.008_bib0043","doi-asserted-by":"crossref","first-page":"1172","DOI":"10.1111\/apt.15540","article-title":"Natural history of autoimmune atrophic gastritis: a prospective, single centre, long-term experience","volume":"50","author":"Miceli","year":"2019","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.dld.2023.02.008_bib0044","doi-asserted-by":"crossref","first-page":"1175","DOI":"10.1111\/j.1440-1746.2012.07116.x","article-title":"Distribution trends of gastric polyps: an endoscopy database analysis of 24 121 northern Chinese patients","volume":"27","author":"Cao","year":"2012","journal-title":"J Gastroenterol Hepatol"},{"key":"10.1016\/j.dld.2023.02.008_bib0045","doi-asserted-by":"crossref","first-page":"878","DOI":"10.1159\/000515213","article-title":"Gastric adenoma: a high incidence rate of developing carcinoma and risk of metachronous gastric cancer according to long-term follow-up","volume":"102","author":"Okamoto","year":"2021","journal-title":"Digestion"}],"container-title":["Digestive and Liver Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1590865823002219?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1590865823002219?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,28]],"date-time":"2025-10-28T04:22:12Z","timestamp":1761625332000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1590865823002219"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,9]]},"references-count":45,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2023,9]]}},"alternative-id":["S1590865823002219"],"URL":"https:\/\/doi.org\/10.1016\/j.dld.2023.02.008","relation":{},"ISSN":["1590-8658"],"issn-type":[{"value":"1590-8658","type":"print"}],"subject":[],"published":{"date-parts":[[2023,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Exploring the spectrum of incidental gastric polyps in autoimmune gastritis","name":"articletitle","label":"Article Title"},{"value":"Digestive and Liver Disease","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.dld.2023.02.008","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Editrice Gastroenterologica Italiana S.r.l. Published by Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}